A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis

Arthritis Research and Therapy

Volumn 10, Issue 2, 2008, Pages

  Smitten, Allison L ^a   Simon, Teresa A ^b   Hochberg, Marc C ^c   Suissa, Samy ^d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; TUMOR NECROSIS FACTOR ANTIBODY;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CLINICAL TRIAL; COHORT ANALYSIS; COLORECTAL CANCER; DATA ANALYSIS; HUMAN; LUNG CANCER; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; POPULATION RESEARCH; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; ADULT; FEMALE; INCIDENCE; MALE; NEOPLASM; RISK FACTOR;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; RISK FACTORS;

EID: 44049085950     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2404     Document Type: Article

References (33)

1. Chakravarty EF Genovese MC Associations between rheumatoid arthritis and malignancy Rheum Dis Clin North Am 2004, 30:271-284. 10.1016/ j.rdc.2004.01.007 15172040
2. DerSimonian R Laird N Meta-analysis in clinical trials Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2 3802833
3. Abásolo L Júdez E Descalzo MA González-Álvaro I Jover JA Carmona L EMECAR Study Group Cancer in rheumatoid arthritis: Occurrence, mortality, and associated factors in a south European population Semin Arthritis Rheum 2007, Oct 29. 17977580
4. Askling J Fored CM Baecklund E Brandt L Backlin C Ekbom A Sundström C Bertilsson L Cöster L Geborek P Jacobsson LT Lindblad S Lysholm J Rantapää-Dahlqvist S Saxne T Klareskog L Feltelius N Haematopoietic malignancies in rheumatoid arthritis: Lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists Ann Rheum Dis 2005, 64:1414-1420. 10.1136/ard.2004.033241 15843454
5. Askling J Fored CM Brandt L Baecklund E Bertilsson L Feltelius N Cöster L Geborek P Jacobsson LT Lindblad S Lysholm J Rantapää-Dahlqvist S Saxne T Klareskog L Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists Ann Rheum Dis 2005, 64:1421-1426. 10.1136/ard.2004.033993 15829572
6. Cibere J Sibley J Haga M Rheumatoid arthritis and the risk of malignancy Arthritis Rheum 1997, 40:1580-1586. 10.1002/art.1780400906 9324011
7. Ekström K Hjalgrim H Brandt L Baecklund E Klareskog L Ekbom A Askling J Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives Arthritis Rheum 2003, 48:963-970. 10.1002/art.10939 12687538
8. Franklin J Lunt M Bunn D Symmons D Silman A Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis Ann Rheum Dis 2006, 65:617-622. 10.1136/ard.2005.044784 16249224
9. Franklin J Lunt M Bunn D Symmons D Silman A Influence of inflammatory polyarthritis on cancer incidence and survival: Results from a community-based prospective study Arthritis Rheum 2007, 56:790-798. 10.1002/art.22430 17328051
10. Geborek P Bladström A Turesson C Gulfe A Petersson IF Saxne T Olsson H Jacobsson LT Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas Ann Rheum Dis 2005, 64:699-703. 1755491 15695534 10.1136/ard.2004.030528
11. Gridley G McLaughlin JK Ekbom A Klareskog L Adami HO Hacker DG Hoover R Fraumeni JF Jr Incidence of cancer among patients with rheumatoid arthritis J Natl Cancer Inst 1993, 85:307-311. 10.1093/jnci/85.4.307 8426374
12. Kauppi M Pukkala E Isomaki H Excess risk of lung cancer in patients with rheumatoid arthritis J Rheumatol 1996, 23:1484-1485. 8856639
13. Kauppi M Pukkala E Isomaki H Low incidence of colorectal cancer in patients with rheumatoid arthritis Clin Exp Rheumatol 1996, 14:551-553. 8913658
14. Kauppi M Pukkala E Isomaki H Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland) Cancer Causes Control 1997, 8:201-204. 10.1023/A:1018472213872 9134244
15. Mariette X Cazals-Hatem D Warszawki J Liote F Balandraud N Sibilia J Lymphomas in rheumatoid arthritis patients treated with methotrexate: A 3-year prospective study in France Blood 2002, 99:3909-3915. 10.1182/ blood.V99.11.3909 12010788
16. Matteson EL Hickey AR Maguire L Tilson HH Urowitz MB Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry. Rheumatoid Arthritis Azathioprine Registry Steering Committee J Rheumatol 1991, 18:809-814. 1895261
17. McKendry RJ Dale P Adverse effects of low dose methotrexate therapy in rheumatoid arthritis J Rheumatol 1993, 20:1850-1856. 8308769
18. Mellemkjaer L Linet MS Gridley G Frisch M Moller H Olsen JH Rheumatoid arthritis and cancer risk Eur J Cancer 1996, 32A:1753-1757. 10.1016/ 0959-8049(96)00210-9 8983286
19. Moritomo H Ueda T Hiyama T Hosono N Mori S Komatsubara Y The risk of cancer in rheumatoid patients in Japan Scand J Rheumatol 1995, 24:157-159. 10.3109/03009749509099305 7777827
20. Setoguchi S Solomon DH Weinblatt ME Katz JN Avorn J Glynn RJ Cook EF Carney G Schneeweiss S Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis Arthritis Rheum 2006, 54:2757-2764. 10.1002/art.22056 16947774
21. Thomas E Brewster DH Black RJ Macfarlane GJ Risk of malignancy among patients with rheumatic conditions Int J Cancer 2000, 88:497-502. 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J 11054684
22. Wolfe F Michaud K The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation Arthritis Rheum 2007, 56:1433-1439. 10.1002/art.22579 17469100
23. Wolfe F Michaud K Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational study Arthritis Rheum 2007, 56:2886-2895. 10.1002/art.22864 17729297
24. Georgescu L Quinn GC Schwartzman S Paget SA Lymphoma in patients with rheumatoid arthritis: Association with disease state or methotrexate treatment Semin Arthritis Rheum 1997, 26:794-804. 10.1016/ S0049-0172(97)80023-6 9213378
25. Baecklund E Iliadou A Askling J Ekbom A Backlin C Granath F Catrina AI Rosenquist R Feltelius N Sundström C Klareskog L Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis Arthritis Rheum 2006, 54:692-701. 10.1002/art.21675 16508929
26. Smedby KE Baecklund E Askling J Malignant lymphomas in autoimmunity and inflammation: A review of risks, risk factors, and lymphoma characteristics Cancer Epidemiol Biomarkers Prev 2006, 15:2069-2077. 10.1158/1055-9965.EPI-06-0300 17119030
27. Askling J Malignancy and rheumatoid arthritis Curr Rheumatol Rep 2007, 9:421-426. 10.1007/s11926-007-0067-1 17915099
28. Strauss GM Cigarette smoking and other risk factors for lung cancer UpToDate Waltham, MA:UPToDate Rose BD 2007.
29. Siemes C Visser LE Coebergh JW Splinter TA Witteman JC Uitterlinden AG Hofman A Pols HA Stricker BH C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: The Rotterdam Study J Clin Oncol 2006, 24:5216-5222. 10.1200/JCO.2006.07.1381 17114654
30. Walker WC Wright V Pulmonary lesions and rheumatoid arthritis Medicine 1968, 47:501-520. 5727884
31. Pincus T Callahan LF Early mortality in RA predicted by poor clinical status Bull Rheum Dis 1992, 41:1-4. 1458266
32. Rostom A Dubé C Lewin G Tsertsvadze A Barrowman N Code C Sampson M Moher D U.S. Preventive Services Task Force Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: A systematic review prepared for the U.S. Preventive Services Task Force Ann Intern Med 2007, 146:376-389. 17339623
33. Subungkot S Frame D Leslie W Drajer D Selective cyclooxygenase-2 inhibition: A target in cancer prevention and treatment Pharmacotherapy 2003, 23:9-28. 10.1592/phco.23.1.9.31916 12523457